期刊文献+

医院获得性肺血栓栓塞症的临床特征与危险因素分析 被引量:2

Analysis of clinical characteristics of and risk factors for hospitalacquired pulmonary thromboembolism
原文传递
导出
摘要 背景与目的:有关医院获得性肺血栓栓塞症(HA-PTE)的流行病学数据大多来自单一病种的调查研究,对于全院范围内HA-PTE的调查研究尚少。因此,本研究对全院范围内HA-PTE患者流行病学及临床特征等进行分析,以期为HA-PTE防治与管理提供参考依据。方法:收集中南大学湘雅医院2018年1月1日—12月31日确诊HA-PTE患者(病例组)的临床资料和实验室检验数据,并根据性别、年龄、入院Caprini血栓风险评分等级、是否接受外科手术及手术等级,按1∶1匹配同期非HA-PTE患者作为对照组。分析HA-PTE患者的发病率、病死率、相关临床病理因素、危险因素及有价值的预测指标等。结果:2018年度122942例住院患者中确诊新发HA-PTE患者68例(0.55‰),无HA-PTE相关死亡病例。42.65%(29/68)的HA-PTE患者同时合并有深静脉血栓形成。HA-PTE患者主要分布在神经内科(14/68,20.59%)、普通外科(11/68,16.18%)和呼吸内科(8/68,11.76%)。单因素分析结果显示,病例组呼吸系统疾病、肺部感染及入住ICU的比例高于较对照组(OR=4.60,95%CI=1.75~12.10,P=0.002;OR=2.38,95%CI=1.04~5.43,P=0.040;OR=11.00,95%CI=1.42~85.20,P=0.022),总住院时长与住院总费用高于对照组(OR=1.11,95%CI=1.05~1.18,P<0.005;OR=1.01,95%CI=1.00~1.03,P=0.005),纤维蛋白原降解产物(FDP)水平高于对照组(OR=1.11,95%CI=1.03~1.20,P=0.004)。多因素分析结果显示,呼吸系统疾病(校正OR=3.58,95%CI=1.32~9.71,P=0.012)和入住ICU(校正OR=11.38,95%CI=1.38~93.54,P=0.024)是HA-PTE的独立危险因素。结论:患有呼吸系统疾病和入住过ICU的患者为HA-PTE的高危人群,神经内科、普通外科和呼吸内科是HA-PTE的高危科室,HA-PTE会导致患者的住院时长和医疗费用显著增高。FDP水平对于HA-PTE可能有一定的预测价值。 Background and Aims:Most of the epidemiological data on hospital-acquired pulmonary thromboembolism(HA-PTE)are from studies focusing on a single disease,but the hospital-wide epidemiological investigation of HA-PTE are still insufficient.Therefore,this study was conducted to analyse the epidemiological and clinical characteristics of HA-PTE in a hospital-wide setting,so as to provide a reference base for prevention and management of HA-PTE.Methods:The clinical and laboratory data of patients with newly diagnosed HA-PTE(case group)in Xiangya Hospital,Central South University from January 1 to December 31,2018 were collected,and inpatients without HA-PTE(control group)during the same period were matched by sex,age,Caprini thrombosis risk score at admission and whether undergoing surgery or not as well as the grade of surgery in a 1:1 ratio.The incidence,mortality,relevant clinicopathologic factors,risk factors and potential predictive indicators for HA-PTE patients were analysed.Results:Among the 122942 inpatients in 2018,a total of 68 cases(0.55‰)were diagnosed with PAPTE and no HA-PTE-related death occurred.There were 42.65%(29/68)HA-PTE cases with concomitant deep venous thrombosis.Majority of HA-PTE cases were from neurology ward(14/68,20.59%),general surgery ward(11/68,16.18%)and respiratory ward(8/68,11.76%).The results of univariate analysis showed that the proportions of cases with diseases of the respiratory system or lung infection and undergoing ICU admission in case group were higher than those in control group(OR=4.60,95%CI=1.75-12.10,P=0.002;OR=2.38,95%CI=1.04-5.43,P=0.040;OR=11.00,95%CI=1.42-85.20,P=0.022),the total length of hospital stay was longer and hospitalization expense was greater in case group than those in control group(OR=1.11,95%CI=1.05-1.18,P<0.005;OR=1.01,95%CI=1.00-1.03,P=0.005),and the level of fibrinogen degradation products(FDP)in case group was higher than that in control group(OR=1.11,95%CI=1.03-1.20,P=0.004).The results of multivariate analysis revealed that diseases of the respiratory system(adjusted OR=3.58,95%CI=1.32-9.71,P=0.012)and ICU stay(adjusted OR=11.38,95%CI=1.38-93.54,P=0.024)were independent risk factors for HA-PTE.Conclusion:Patients with diseases of the respiratory system or undergoing ICU stay are high-risk population for HA-PTE.Patients in neurology,general surgery and respiratory wards are at higher risk of HA-PTE.HA-PTE will result in significant prolonged hospital stay and increased medical costs.FDP level may have certain predictive value for HA-PTE.
作者 赵声远 王丽倩 贺爱兰 梁湘辉 杨奥烽 黄建华 王伟 唐红英 ZHAO Shengyuan;WANG Liqian;HE Ailan;LIANG Xianghui;YANG Aofeng;HUANG Jianhua;WANGWei;TANG Hongying(Department of Laboratory Medicine,Xiangya Hospital,Central South University,Changsha,410008,China;Department of Clinical Nursing,Xiangya Hospital,Central South University,Changsha,410008,China;Department of Otolaryngology,Xiangya Hospital,Central South University,Changsha,410008,China;Department of Nursing,Xiangya Hospital,Central South University,Changsha,410008,China;Xiangya School of Medicine,Central South University,Changsha 410013,China;Department of Vascular Surgery,Xiangya Hospital,Central South University,Changsha,410008,China;Reproductive Medicine Center,Xiangya Hospital,Central South University,Changsha,410008,China)
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2022年第6期813-821,共9页 China Journal of General Surgery
基金 中南大学湘雅医院2020年度国家老年疾病临床医学研究中心适宜技术推广基金资助项目(XYYYJSTG-07)。
关键词 肺栓塞 医原性疾病 危险因素 Pulmonary Embolism Iatrogenic Disease Risk Factors
  • 相关文献

参考文献13

二级参考文献108

  • 1周旭辉,李子平,谭国胜,李向民,孟悛非,范淼.急性大面积肺动脉血栓栓塞症溶栓治疗的动态CT观察[J].中华放射学杂志,2005,39(3):256-261. 被引量:37
  • 2国家"十五"攻关"肺栓塞规范化诊治方法的研究"课题组,杨媛华,翟振国,武燕兵,王辰.急性肺血栓栓塞症患者516例临床表现分析[J].中华医学杂志,2006,86(31):2161-2165. 被引量:78
  • 3王兰.超声心动图在肺栓塞诊断中的应用价值[J].第四军医大学学报,2007,28(16):1533-1533. 被引量:7
  • 4陆芸,马宝通,郭若霖,张建国,吴英华,庞贵根,辛景义,叶伟胜,邹玉安,王毅,董强,王学谦,Kerry H,Paul C,John F.骨科创伤患者深静脉血栓危险因素的研究[J].中华骨科杂志,2007,27(9):693-698. 被引量:244
  • 5Prandoni P, Piccioli A, Girolami A. Cancer and venousthromboembolism: an overview[J]. Haematologica, 1999, 84(5):437-445.
  • 6Luzzatto G, Schafer AL The prethrombotic state in cancer[J], SeminOncol, 1990, 17(2):147-159.
  • 7Jarrett BP, Dougherty MJ, Calligaro KD. Inferior vena cava filters inmalignant disease[J]. J Vase Surg, 2002, 36(4):704-707.
  • 8Cushman M. Epidemiology and risk factors for venous thrombosis[J].Semin Hematol, 2007, 44(2):62-69.
  • 9Agnelli G,Bolis G, Capussotti L, et al. A clinical outcome-basedprospective study on venous thromboembolism after cancer surgery:the @RISTOS project[J]. Ann Surg, 2006, 243(1):89-95.
  • 10Caine GJ, Stonelake PS, Lip GY, et al. The hypercoagulable state ofmalignancy : pathogenesis and current debate[J]. Neoplasia,2002,4(6):465-473.

共引文献1097

同被引文献14

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部